Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2005 3
2006 1
2008 1
2009 2
2010 2
2011 1
2012 1
2013 1
2014 4
2015 3
2016 3
2017 1
2018 3
2019 3
2020 7
2021 6
2022 8
2023 5
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Results by year

Filters applied: . Clear all
Page 1
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, Nissen SE, Pocock S, Poulter NR, Ravn LS, Steinberg WM, Stockner M, Zinman B, Bergenstal RM, Buse JB; LEADER Steering Committee; LEADER Trial Investigators. Marso SP, et al. N Engl J Med. 2016 Jul 28;375(4):311-22. doi: 10.1056/NEJMoa1603827. Epub 2016 Jun 13. N Engl J Med. 2016. PMID: 27295427 Free PMC article. Clinical Trial.
Nicotine chemistry, metabolism, kinetics and biomarkers.
Benowitz NL, Hukkanen J, Jacob P 3rd. Benowitz NL, et al. Among authors: hukkanen j. Handb Exp Pharmacol. 2009;(192):29-60. doi: 10.1007/978-3-540-69248-5_2. Handb Exp Pharmacol. 2009. PMID: 19184645 Free PMC article. Review.
Inhibition and induction of CYP enzymes in humans: an update.
Hakkola J, Hukkanen J, Turpeinen M, Pelkonen O. Hakkola J, et al. Among authors: hukkanen j. Arch Toxicol. 2020 Nov;94(11):3671-3722. doi: 10.1007/s00204-020-02936-7. Epub 2020 Oct 27. Arch Toxicol. 2020. PMID: 33111191 Free PMC article. Review.
Metabolism and disposition kinetics of nicotine.
Hukkanen J, Jacob P 3rd, Benowitz NL. Hukkanen J, et al. Pharmacol Rev. 2005 Mar;57(1):79-115. doi: 10.1124/pr.57.1.3. Pharmacol Rev. 2005. PMID: 15734728 Review.
Liraglutide and Renal Outcomes in Type 2 Diabetes.
Mann JFE, Ørsted DD, Brown-Frandsen K, Marso SP, Poulter NR, Rasmussen S, Tornøe K, Zinman B, Buse JB; LEADER Steering Committee and Investigators. Mann JFE, et al. N Engl J Med. 2017 Aug 31;377(9):839-848. doi: 10.1056/NEJMoa1616011. N Engl J Med. 2017. PMID: 28854085 Free article. Clinical Trial.
Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial.
von Herrath M, Bain SC, Bode B, Clausen JO, Coppieters K, Gaysina L, Gumprecht J, Hansen TK, Mathieu C, Morales C, Mosenzon O, Segel S, Tsoukas G, Pieber TR; Anti-IL-21–liraglutide Study Group investigators and contributors. von Herrath M, et al. Lancet Diabetes Endocrinol. 2021 Apr;9(4):212-224. doi: 10.1016/S2213-8587(21)00019-X. Epub 2021 Mar 1. Lancet Diabetes Endocrinol. 2021. PMID: 33662334 Clinical Trial.
CYP-associated drug-drug interactions: A mission accomplished?
Pelkonen O, Hakkola J, Hukkanen J, Turpeinen M. Pelkonen O, et al. Among authors: hukkanen j. Arch Toxicol. 2020 Nov;94(11):3931-3934. doi: 10.1007/s00204-020-02912-1. Epub 2020 Oct 6. Arch Toxicol. 2020. PMID: 33025068
52 results